The Prognostic Importance of TAPSE in Early and in Stable Cardiovascular Diseases

Paolo Giovanardi1,2, Enrico Tincani3, Marco Maioli4

  • 1Cardiology Service, Department of Primary Care, Azienda USL, Via del Pozzo N 71, 41100 Modena, Italy.

Insights

Tricuspid annular plane systolic excursion (TAPSE) effectively predicts major cardiovascular events and mortality in patients with cardiovascular risk factors. Implementing TAPSE can improve risk stratification in early and stable cardiovascular disease.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiovascular Risk Assessment

Background:

  • Identifying predictors of major cardiovascular events (MACES) is crucial, particularly in early and stable cardiovascular diseases.
  • Existing methods for risk stratification may not fully capture prognostic information in these patient groups.

Purpose of the Study:

  • To comparatively evaluate the prognostic importance of various echocardiographic parameters, including ventricular function and pulmonary hemodynamics, for predicting MACES.
  • To determine the independent predictive value of tricuspid annular plane systolic excursion (TAPSE) for cardiovascular outcomes.

Main Methods:

  • Prospective study of 369 subjects with cardiovascular risk factors, assessing left and right ventricular function, pulmonary artery pressure (PAP), and pulmonary vascular resistance (PVR) at baseline.
  • Follow-up recorded MACES and all-cause mortality.
  • Statistical analysis included bivariate and Cox regression models to identify independent predictors.

Main Results:

  • Bivariate analysis showed associations between LVEF, TAPSE, MPAP, TRV, PVR, LV diastolic function, and FMR with endpoints.
  • Cox analysis revealed LV diastolic function and TAPSE predicted the primary endpoint (MACES and all-cause mortality).
  • TAPSE independently predicted the secondary endpoint (MACES).

Conclusions:

  • TAPSE is a valuable and independent predictor of MACES and all-cause mortality in patients with early and stable cardiovascular diseases.
  • The study supports the implementation of TAPSE in routine clinical practice for enhanced risk stratification.
  • Further research may explore the integration of TAPSE with other biomarkers for comprehensive cardiovascular risk assessment.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
324
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
715
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
159
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
310
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
543
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
805